EP3710011C0 - Triterpènes pentacycliques dans le traitement d'une pathologie bucco-dentaire - Google Patents

Triterpènes pentacycliques dans le traitement d'une pathologie bucco-dentaire

Info

Publication number: EP3710011C0
Authority: EP; European Patent Office
Prior art keywords: treatment; oral disease; pentacyclic triterpenes; pentacyclic; triterpenes
Prior art date: 2017-11-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

EP18803636.2A

Other languages

German (de)

English (en)

Other versions

EP3710011A1 (fr

EP3710011B1 (fr

Inventor

Martine Maitre

Thien Nguyen

Adrien Cousy

Fabrice Lestienne

Nicolas Steward

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Medicament SA

Original Assignee

Pierre Fabre Medicament SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-11-13

Filing date

2018-11-13

Publication date

2023-11-29

2018-11-13 Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA

2020-09-23 Publication of EP3710011A1 publication Critical patent/EP3710011A1/fr

2023-11-29 Application granted granted Critical

2023-11-29 Publication of EP3710011C0 publication Critical patent/EP3710011C0/fr

2023-11-29 Publication of EP3710011B1 publication Critical patent/EP3710011B1/fr

Status Active legal-status Critical Current

2038-11-13 Anticipated expiration legal-status Critical

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP18803636.2A 2017-11-13 2018-11-13 Triterpènes pentacycliques dans le traitement d'une pathologie bucco-dentaire Active EP3710011B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1760662A FR3073398B1 (fr)	2017-11-13	2017-11-13	Triterpenes pentacycliques dans le traitement d'une pathologie bucco-dentaire
PCT/EP2018/081076 WO2019092274A1 (fr)	2017-11-13	2018-11-13	Triterpènes pentacycliques dans le traitement d'une pathologie bucco-dentaire

Publications (3)

Publication Number	Publication Date
EP3710011A1 EP3710011A1 (fr)	2020-09-23
EP3710011C0 true EP3710011C0 (fr)	2023-11-29
EP3710011B1 EP3710011B1 (fr)	2023-11-29

Family

ID=61258357

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP18803636.2A Active EP3710011B1 (fr)	2017-11-13	2018-11-13	Triterpènes pentacycliques dans le traitement d'une pathologie bucco-dentaire

Country Status (6)

Country	Link
EP (1)	EP3710011B1 (fr)
AR (1)	AR114030A1 (fr)
FR (1)	FR3073398B1 (fr)
MA (1)	MA50891A (fr)
PL (1)	PL3710011T3 (fr)
WO (1)	WO2019092274A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110507660A (zh) *	2019-09-24	2019-11-29	吉林大学	五环三萜类化合物在制备细菌性溶血素抑制剂中的用途
CN114010645A (zh) *	2021-12-20	2022-02-08	东北农业大学	雷公藤红素在制备抑制金黄色葡萄球菌药物中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100589951B1 (ko) *	1999-03-12	2006-06-15	주식회사 엘지생활건강	노박덩굴 추출물을 함유한 구강조성물
CN102309494A (zh) *	2010-07-01	2012-01-11	嘉兴学院	扁蒴藤素作为炎性细胞因子抑制剂的医药用途

2017
- 2017-11-13 FR FR1760662A patent/FR3073398B1/fr active Active
2018
- 2018-11-13 EP EP18803636.2A patent/EP3710011B1/fr active Active
- 2018-11-13 MA MA050891A patent/MA50891A/fr unknown
- 2018-11-13 PL PL18803636.2T patent/PL3710011T3/pl unknown
- 2018-11-13 AR ARP180103317A patent/AR114030A1/es unknown
- 2018-11-13 WO PCT/EP2018/081076 patent/WO2019092274A1/fr not_active Ceased

Also Published As

Publication number	Publication date
FR3073398B1 (fr)	2020-09-11
PL3710011T3 (pl)	2024-03-11
MA50891A (fr)	2020-09-23
FR3073398A1 (fr)	2019-05-17
WO2019092274A1 (fr)	2019-05-16
EP3710011A1 (fr)	2020-09-23
AR114030A1 (es)	2020-07-15
EP3710011B1 (fr)	2023-11-29

Legal Events

Date	Code	Title	Description
2018-11-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: UNKNOWN
2019-05-18	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2020-08-21	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2020-08-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2020-09-23	17P	Request for examination filed	Effective date: 20200515
2020-09-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2020-09-23	AX	Request for extension of the european patent	Extension state: BA ME
2021-02-17	DAX	Request for extension of the european patent (deleted)
2021-02-17	RAV	Requested validation state of the european patent: fee paid	Extension state: TN Effective date: 20200515 Extension state: MA Effective date: 20200515
2022-03-16	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: PIERRE FABRE MEDICAMENT
2023-03-22	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2023-03-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2023-04-19	INTG	Intention to grant announced	Effective date: 20230323
2023-06-14	GRAJ	Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted	Free format text: ORIGINAL CODE: EPIDOSDIGR1
2023-06-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2023-06-29	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2023-06-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2023-07-19	INTC	Intention to grant announced (deleted)
2023-07-26	INTG	Intention to grant announced	Effective date: 20230630
2023-10-11	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2023-10-27	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2023-10-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2023-11-29	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2023-11-29	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH
2023-11-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2023-12-14	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602018061904 Country of ref document: DE
2023-12-20	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH
2024-01-24	U01	Request for unitary effect filed	Effective date: 20231220
2024-01-24	U07	Unitary effect registered	Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20240103
2024-02-14	REG	Reference to a national code	Ref country code: GR Ref legal event code: EP Ref document number: 20240400040 Country of ref document: GR Effective date: 20240209
2024-04-09	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240329
2024-04-26	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129
2024-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240329 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129
2024-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240229 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129
2024-07-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129
2024-07-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129
2024-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129
2024-08-30	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602018061904 Country of ref document: DE
2024-10-03	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2024-10-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2024-11-06	26N	No opposition filed	Effective date: 20240830
2024-12-04	U20	Renewal fee for the european patent with unitary effect paid	Year of fee payment: 7 Effective date: 20241025
2025-06-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2025-07-07	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231129
2025-07-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2025-07-23	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20241113
2025-07-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241130
2025-10-16	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241113
2025-10-22	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20241113
2025-12-03	U20	Renewal fee for the european patent with unitary effect paid	Year of fee payment: 8 Effective date: 20251028
2026-01-16	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GR Payment date: 20251024 Year of fee payment: 8
2026-01-23	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: PL Payment date: 20251020 Year of fee payment: 8
2026-03-06	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20181113
2026-03-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20181113
2026-04-15	VS25	Lapsed in a validation state [announced via postgrant information from nat. office to epo]	Ref country code: MA Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20181113

Publication	Publication Date	Title
EP3634417C0 (fr)	2023-07-12	Dérivés quinazoline-pyrazole pour le traitement de troubles liés au cancer
HUE060711T2 (hu)	2023-04-28	Makrociklusos vegyületek betegségek kezelésére
EP3448874A4 (fr)	2020-04-22	Compositions pour le traitement de maladies
PL3600309T3 (pl)	2022-11-07	Skojarzenia terapeutyczne do leczenia chorób wątroby
IL268850A (en)	2019-10-31	Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
EP3263132C0 (fr)	2023-12-06	Composition pour le traitement de maladies associées à il-6
EP3362013C0 (fr)	2024-12-04	Dispositif energetique pour le traitement d'un trouble oculaire
ZA201703346B (en)	2020-10-28	Conjugated bisphosphonates for the diagnosis and therapy of bone diseases
EP3915472C0 (fr)	2025-10-22	Dispositif pour traiter l'atrophie vaginale
HUE059752T2 (hu)	2022-12-28	A danon betegség és az autofágia egyéb rendellenességeinek kezelésére szolgáló módszerek
IL269158A (en)	2019-11-28	Compositions and methods for treating inflammatory diseases
EP4088724C0 (fr)	2024-10-23	Inhibiteurs de l'acétylcholinestérase pour le traitement oral d'états dermatologiques
EP3544614A4 (fr)	2020-08-05	Traitement oral à base d'undécanoate de testostérone
LT3157531T (lt)	2021-07-12	Žarnyno enteroendokrininės sistemos stimuliavimo būdai ir kompozicijos, skirtos su ja susijusioms ligoms arba būklėms gydyti
ZA201906213B (en)	2022-03-30	Compounds and methods for the treatment of parasitic diseases
IL272937A (en)	2020-04-30	Preparations and methods for the treatment of diseases involving fibrosis
EP3253395C0 (fr)	2025-10-29	Préparation probiotique pour le traitement de l'inflammation intestinale
EP3137907A4 (fr)	2018-02-28	Procédés et compositions pour le diagnostic et le traitement de la maladie de kawasaki
FR3020951B1 (fr)	2016-06-17	Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique.
EP2946777C0 (fr)	2023-10-04	Médicament pour le traitement d'une maladie neuropathique
EP3710011C0 (fr)	2023-11-29	Triterpènes pentacycliques dans le traitement d'une pathologie bucco-dentaire
ZA201903572B (en)	2022-04-28	Compositions and methods for the treatment of oral infectious diseases
HUE055374T2 (hu)	2021-11-29	Eljárás Lenvatinib elõállítására
IL246944B (en)	2019-11-28	A process for the preparation of abiraterone acetate and its intermediates
EP3663309C0 (fr)	2024-01-03	Glycosides stéroïdiens extraits de la plante furcraea foetida pour le traitement d'affections cutanées